small molecule

FORFIVO XL

BUPROPION HYDROCHLORIDE

Loss of exclusivityAugust 2028latest FDA-listed patent expiry
CompanyTWI PHARMACEUTICALS INC

Drug detail

Brand nameFORFIVO XL
Active ingredientBUPROPION HYDROCHLORIDE
Strength450MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2011
Marketing statusRX

Listed patents

PatentExpiresType
7674479August 2028product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.